Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC
Clinical trial NCT07769866 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07769866
- Sponsor
- RenJi Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2029-06-30
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.